Hope for Reversing Stroke-induced Long-term Disability
A human protein combined with stem cell therapy has been found to repair stroke damage to the brain, according to a new USC-led study on mice
Permanent brain damage from a stroke may be reversible thanks to a developing therapeutic technique, a USC-led study has found. The novel approach combines transplanted human stem cells with a special protein that the U.S. Food and Drug Administration (FDA) already approved for clinical studies in new stroke patients. “This USC-led animal study could pave the way for a potential breakthrough in how we treat people who have experienced a stroke,” said Jim Koenig, a program director at the National Institute of Neurological Disorders and Stroke, which funded the research. “If the therapy works in humans, it could markedly accelerate the recovery of these patients.” To read more, click here.
Microsurgical Approaches to Aneurysms and Skull Base Diseases 2017
Oct. 26-28, 2017; Jacksonville, Fla.
Pituitary Tumors: Diagnostic and Treatment Dilemmas
Oct. 27, 2017; New York
GOODMAN Oral Board Preparation Course Tumor
Nov. 1-3, 2017; Glendale, Ariz.
8th World Congress of Neuroendoscopy
Nov. 1-4, 2017; Cape Town, South Africa
3rd Annual Selected Topics in Craniomaxillofacial Surgery
Nov. 4, 2017 - Nov. 5, 2017; Boston, Mass.